Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome

P. Bosco, R. Ferri, F. Cali, A. Indelicato, R. M. Ragusa, A. Argiolas, F. Scillato, G. Corsello, M. Cammarata, L. Giuffre, G. Garofalo, N. Ceratto, V. Romano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Fragile X (FRAXA) or Martin-Bell (MB) syndrome is a common inherited form of mental retardation (MR). Diagnosis relies on the appearance of MR of variable degree and several dysmorphic features usually involving the connective tissue. However, identification of Martin-Bell (MB) patients may be difficult because the FRAXA clinical phenotype shows variable expressivity. A similar consideration also concerns the degree of expression of the fragile site in Xq27.3 on which cytogenetic diagnosis relies. The prevalence is estimated to be 1 in 1,250 males and 1 in 2,500 females (1, 2). Unexpectedly, for an X-linked trait, normal transmitting males (NTMs) have been described in fragile X pedigrees. Furthermore, the risk of manifesting the MB phenotype depends on the position of affected individuals in the pedigree. The latter observation is also known as the Sherman's paradox (3, 4). In the present study me report the results of FMR-1 gene analysis with probe StB12.3 (5) in mentally retarded individuals and relatives evoking the phenotype of MB syndrome. In order to exploit the potential use of DNA analysis for predicting the fragile X phenotype, a preliminary analysis on the correlation between mutation severity (triplet expansion) and cytogenetic expression has been carried out.

Original languageEnglish
Pages (from-to)149-151
Number of pages3
JournalBulletin of Molecular Biology and Medicine
Volume20
Issue number3-4
Publication statusPublished - 1995

Fingerprint

Fragile X Syndrome
Ferromagnetic resonance
Genes
Phenotype
Pedigree
Cytogenetics
Intellectual Disability
X-Linked Genes
Mentally Disabled Persons
Connective Tissue
Observation
Tissue
Mutation
DNA

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome. / Bosco, P.; Ferri, R.; Cali, F.; Indelicato, A.; Ragusa, R. M.; Argiolas, A.; Scillato, F.; Corsello, G.; Cammarata, M.; Giuffre, L.; Garofalo, G.; Ceratto, N.; Romano, V.

In: Bulletin of Molecular Biology and Medicine, Vol. 20, No. 3-4, 1995, p. 149-151.

Research output: Contribution to journalArticle

Bosco, P, Ferri, R, Cali, F, Indelicato, A, Ragusa, RM, Argiolas, A, Scillato, F, Corsello, G, Cammarata, M, Giuffre, L, Garofalo, G, Ceratto, N & Romano, V 1995, 'Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome', Bulletin of Molecular Biology and Medicine, vol. 20, no. 3-4, pp. 149-151.
Bosco, P. ; Ferri, R. ; Cali, F. ; Indelicato, A. ; Ragusa, R. M. ; Argiolas, A. ; Scillato, F. ; Corsello, G. ; Cammarata, M. ; Giuffre, L. ; Garofalo, G. ; Ceratto, N. ; Romano, V. / Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome. In: Bulletin of Molecular Biology and Medicine. 1995 ; Vol. 20, No. 3-4. pp. 149-151.
@article{6ac225433c6840d6a3933e4af6e2c40f,
title = "Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome",
abstract = "Fragile X (FRAXA) or Martin-Bell (MB) syndrome is a common inherited form of mental retardation (MR). Diagnosis relies on the appearance of MR of variable degree and several dysmorphic features usually involving the connective tissue. However, identification of Martin-Bell (MB) patients may be difficult because the FRAXA clinical phenotype shows variable expressivity. A similar consideration also concerns the degree of expression of the fragile site in Xq27.3 on which cytogenetic diagnosis relies. The prevalence is estimated to be 1 in 1,250 males and 1 in 2,500 females (1, 2). Unexpectedly, for an X-linked trait, normal transmitting males (NTMs) have been described in fragile X pedigrees. Furthermore, the risk of manifesting the MB phenotype depends on the position of affected individuals in the pedigree. The latter observation is also known as the Sherman's paradox (3, 4). In the present study me report the results of FMR-1 gene analysis with probe StB12.3 (5) in mentally retarded individuals and relatives evoking the phenotype of MB syndrome. In order to exploit the potential use of DNA analysis for predicting the fragile X phenotype, a preliminary analysis on the correlation between mutation severity (triplet expansion) and cytogenetic expression has been carried out.",
author = "P. Bosco and R. Ferri and F. Cali and A. Indelicato and Ragusa, {R. M.} and A. Argiolas and F. Scillato and G. Corsello and M. Cammarata and L. Giuffre and G. Garofalo and N. Ceratto and V. Romano",
year = "1995",
language = "English",
volume = "20",
pages = "149--151",
journal = "Bulletin of Molecular Biology and Medicine",
issn = "0391-481X",
number = "3-4",

}

TY - JOUR

T1 - Analysis of the FMR-1 gene and correlation with phenotype in Sicilian families with the fragile X syndrome

AU - Bosco, P.

AU - Ferri, R.

AU - Cali, F.

AU - Indelicato, A.

AU - Ragusa, R. M.

AU - Argiolas, A.

AU - Scillato, F.

AU - Corsello, G.

AU - Cammarata, M.

AU - Giuffre, L.

AU - Garofalo, G.

AU - Ceratto, N.

AU - Romano, V.

PY - 1995

Y1 - 1995

N2 - Fragile X (FRAXA) or Martin-Bell (MB) syndrome is a common inherited form of mental retardation (MR). Diagnosis relies on the appearance of MR of variable degree and several dysmorphic features usually involving the connective tissue. However, identification of Martin-Bell (MB) patients may be difficult because the FRAXA clinical phenotype shows variable expressivity. A similar consideration also concerns the degree of expression of the fragile site in Xq27.3 on which cytogenetic diagnosis relies. The prevalence is estimated to be 1 in 1,250 males and 1 in 2,500 females (1, 2). Unexpectedly, for an X-linked trait, normal transmitting males (NTMs) have been described in fragile X pedigrees. Furthermore, the risk of manifesting the MB phenotype depends on the position of affected individuals in the pedigree. The latter observation is also known as the Sherman's paradox (3, 4). In the present study me report the results of FMR-1 gene analysis with probe StB12.3 (5) in mentally retarded individuals and relatives evoking the phenotype of MB syndrome. In order to exploit the potential use of DNA analysis for predicting the fragile X phenotype, a preliminary analysis on the correlation between mutation severity (triplet expansion) and cytogenetic expression has been carried out.

AB - Fragile X (FRAXA) or Martin-Bell (MB) syndrome is a common inherited form of mental retardation (MR). Diagnosis relies on the appearance of MR of variable degree and several dysmorphic features usually involving the connective tissue. However, identification of Martin-Bell (MB) patients may be difficult because the FRAXA clinical phenotype shows variable expressivity. A similar consideration also concerns the degree of expression of the fragile site in Xq27.3 on which cytogenetic diagnosis relies. The prevalence is estimated to be 1 in 1,250 males and 1 in 2,500 females (1, 2). Unexpectedly, for an X-linked trait, normal transmitting males (NTMs) have been described in fragile X pedigrees. Furthermore, the risk of manifesting the MB phenotype depends on the position of affected individuals in the pedigree. The latter observation is also known as the Sherman's paradox (3, 4). In the present study me report the results of FMR-1 gene analysis with probe StB12.3 (5) in mentally retarded individuals and relatives evoking the phenotype of MB syndrome. In order to exploit the potential use of DNA analysis for predicting the fragile X phenotype, a preliminary analysis on the correlation between mutation severity (triplet expansion) and cytogenetic expression has been carried out.

UR - http://www.scopus.com/inward/record.url?scp=0029419452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029419452&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 149

EP - 151

JO - Bulletin of Molecular Biology and Medicine

JF - Bulletin of Molecular Biology and Medicine

SN - 0391-481X

IS - 3-4

ER -